一个令人惊叹的化学疗法引起的肺炎病例
Anthony V Cook1, David I LeRoy1, Cassie T Konja1
1Internal Medicine, Henry Ford Health System - Warren, Warren, USA.
Cureus
|March 13, 2025
概括
一种化疗药物埃托,很少会导致肺部毒性,如肺炎. 这一案例凸显了在癌症治疗期间患有急性呼吸衰竭的患者中考虑以太胺诱导的肺炎的重要性.
科学领域:
- 在瘤学瘤学.
- 肺部医学 肺部医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 药物诱导的肺毒性是一种罕见但严重的不良事件,与各种化疗剂有关.
- 通常用于生殖细胞瘤和其他癌症,已知会引起包括肺炎在内的毒性.
- 在化疗期间或之后的急性呼吸衰竭需要仔细考虑药物诱导的肺损伤.
研究的目的:
- 报告一种异常的埃托波胺诱导性肺炎病例.
- 强调诊断化疗引起的肺毒性的重要性.
主要方法:
- 一个患有转移性半瘤的病人的病例报告.
- 对临床表现和治疗过程的审查.
- 对急性呼吸衰竭的差异诊断的考虑.
主要成果:
- 患者在短时间内静脉注射埃托波西德后出现了肺炎.
- 考虑到治疗时间,这种不良事件是意想不到的.
结论:
- 即使在短时间的治疗疗程后,也可能发生由乙氧化物诱导的肺炎.
- 临床医生应在接受埃托化疗的患者中保持高的肺毒性怀疑指数.
相关概念视频
01:30Pneumonia I: Introduction
201
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
201
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
01:28Pneumonia IV: Management
283
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
283
01:30Pneumonia III: Complications and Assessment
137
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
137
01:29Pneumonia II: Pathophysiology
197
The pathophysiology of pneumonia involves the following steps:
197
01:27Pneumothorax-II
111
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
111